Loading company…
Trius Therapeutics developed antibiotic therapies for serious infections caused by resistant bacteria.
Founded in 2004 and based in San Diego, US, Trius Therapeutics developed antibiotics for serious infections, particularly those caused by multidrug-resistant bacteria. In August 2010, it raised USD 25.00 mn in a PIPE round, including investment from Terrapin Opportunity. The supplied information also describes TriusRx medication management services for patients with complex conditions.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in